Song M - Search Results

1

Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL).

Tsai TF, Ho JC, Song M, Szapary P, Guzzo C, Shen YK, Li S, Kim KJ, Kim TY, Choi JH, Youn JI; PEARL Investigators. Tsai TF, et al. Among authors: song m. J Dermatol Sci. 2011 Sep;63(3):154-63. doi: 10.1016/j.jdermsci.2011.05.005. Epub 2011 May 20. J Dermatol Sci. 2011. PMID: 21741220 Clinical Trial.

2

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.

Tsai TF, Ho V, Song M, Szapary P, Kato T, Wasfi Y, Li S, Shen YK, Leonardi C; PHOENIX 1, PHOENIX 2, ACCEPT, PEARL and Japanese Ustekinumab Study Groups. Tsai TF, et al. Among authors: song m. Br J Dermatol. 2012 Nov;167(5):1145-52. doi: 10.1111/j.1365-2133.2012.11142.x. Br J Dermatol. 2012. PMID: 22803615 Clinical Trial.

3

Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.

Tsai TF, Song M, Shen YK, Schenkel B, Choe YB, Kim NI, Lee JH, Lee JH, Song HJ, Youn JI; PEARL investigators. Tsai TF, et al. Among authors: song hj, song m. J Drugs Dermatol. 2012 Aug;11(8):943-9. J Drugs Dermatol. 2012. PMID: 22859239 Clinical Trial.

4

Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS).

Zhu X, Zheng M, Song M, Shen YK, Chan D, Szapary PO, Wang B; LOTUS Investigators. Zhu X, et al. Among authors: song m. J Drugs Dermatol. 2013 Feb;12(2):166-74. J Drugs Dermatol. 2013. PMID: 23377389 Clinical Trial.

5

Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial.

Armstrong A, Puig L, Langley R, Tsai TF, Song M, Wasfi Y, Jiang J, Li S, Han C. Armstrong A, et al. Among authors: song m. J Dermatolog Treat. 2019 Feb;30(1):27-34. doi: 10.1080/09546634.2017.1364694. Epub 2018 Sep 24. J Dermatolog Treat. 2019. PMID: 28797188 Free article. Clinical Trial.

6

Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2.

Reich K, Song M, Li S, Jiang J, Youn SW, Tsai TF, Choe YB, Huang YH, Gordon KB. Reich K, et al. Among authors: song m. J Dermatol. 2019 Dec;46(12):1141-1152. doi: 10.1111/1346-8138.15109. Epub 2019 Oct 20. J Dermatol. 2019. PMID: 31631377 Clinical Trial.

7

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.

Langley RG, Tsai TF, Flavin S, Song M, Randazzo B, Wasfi Y, Jiang J, Li S, Puig L. Langley RG, et al. Among authors: song m. Br J Dermatol. 2018 Jan;178(1):114-123. doi: 10.1111/bjd.15750. Epub 2017 Oct 10. Br J Dermatol. 2018. PMID: 28635018 Clinical Trial.

8

Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.

Gordon KB, Blauvelt A, Foley P, Song M, Wasfi Y, Randazzo B, Shen YK, You Y, Griffiths CEM. Gordon KB, et al. Among authors: song m. Br J Dermatol. 2018 Jan;178(1):132-139. doi: 10.1111/bjd.16008. Epub 2017 Dec 14. Br J Dermatol. 2018. PMID: 28940259 Clinical Trial.

9

Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies.

Reich K, Papp KA, Armstrong AW, Wasfi Y, Li S, Shen YK, Randazzo B, Song M, Kimball AB. Reich K, et al. Among authors: song m. Br J Dermatol. 2019 May;180(5):1039-1049. doi: 10.1111/bjd.17454. Br J Dermatol. 2019. PMID: 30485400 Clinical Trial.

10

Efficacy and Safety of Toreforant, a Selective Histamine H4 Receptor Antagonist, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Frankel E, Song M, Li S, Jiang J, Thurmond RL, Randazzo B. Frankel E, et al. Among authors: song m. J Drugs Dermatol. 2018 Aug 1;17(8):873-879. J Drugs Dermatol. 2018. PMID: 30124726 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,328 results

Search Page

Filters